Andrew Hollman Meyer

Insider Reports History

Location: C/O Janux Therapeutics, Inc., 11099 N. Torrey Pines Road, Suite 290, La Jolla, CA
Signature: /s/ James Pennington, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Hollman Meyer:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Janux Therapeutics, Inc.	Chief Business Officer	Common Stock	82.1K	$2.68M	$32.60	May 1, 2025	Direct
Janux Therapeutics, Inc.	Chief Business Officer	Stock Option (right to buy)	87.3K			May 1, 2025	Direct

Showing 1 to 2 of 2 entries

Insider Reports Filed by Andrew Hollman Meyer

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
JANX	Janux Therapeutics, Inc.	May 1, 2025	4	-$92.7K	4	May 2, 2025	Chief Business Officer
JANX	Janux Therapeutics, Inc.	Apr 21, 2025	3	-$86K	4	Apr 23, 2025	Chief Business Officer
JANX	Janux Therapeutics, Inc.	Mar 3, 2025	4	-$93.1K	4	Mar 5, 2025	Chief Business Officer
JANX	Janux Therapeutics, Inc.	Feb 3, 2025	5	-$127K	4	Feb 5, 2025	Chief Business Officer
JANX	Janux Therapeutics, Inc.	Jan 2, 2025	7	-$732K	4	Jan 3, 2025	Chief Business Officer
JANX	Janux Therapeutics, Inc.	Dec 19, 2024	4	$200K	4	Dec 20, 2024	Chief Business Officer
JANX	Janux Therapeutics, Inc.	Sep 27, 2024	3	-$2.09M	4	Sep 27, 2024	Chief Business Officer
JANX	Janux Therapeutics, Inc.	Jan 2, 2024	1	$0	4	Jan 3, 2024	Chief Business Officer
JANX	Janux Therapeutics, Inc.	Jan 3, 2023	1	$0	4	Jan 5, 2023	Chief Business Officer
JANX	Janux Therapeutics, Inc.	Jan 3, 2022	1	$0	4	Jan 5, 2022	Chief Business Officer
JANX	Janux Therapeutics, Inc.	Jun 10, 2021	0	$0	3	Jun 10, 2021	Chief Business Officer